Annual Total Liabilities
$17.98 M
+$7.45 M+70.78%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual total liabilities is $17.98 million, with the most recent change of +$7.45 million (+70.78%) on December 1, 2023.
- During the last 3 years, RVPH annual total liabilities has risen by +$14.69 million (+445.48%).
- RVPH annual total liabilities is now at all-time high.
Performance
RVPH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$17.61 M
+$3.52 M+24.96%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly total liabilities is $17.61 million, with the most recent change of +$3.52 million (+24.96%) on September 1, 2024.
- Over the past year, RVPH quarterly total liabilities has increased by +$3.71 million (+26.64%).
- RVPH quarterly total liabilities is now -2.06% below its all-time high of $17.98 million, reached on December 1, 2023.
Performance
RVPH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RVPH Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.8% | +26.6% |
| 3 y3 years | +445.5% | +72.3% |
| 5 y5 years | +163.9% | +72.3% |
RVPH Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +561.7% | -2.1% | +548.1% |
| 5 y | 5-year | at high | +561.7% | -2.1% | +984.1% |
| alltime | all time | at high | +561.7% | -2.1% | +984.1% |
Reviva Pharmaceuticals Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.61 M(+25.0%) |
| Jun 2024 | - | $14.09 M(-5.0%) |
| Mar 2024 | - | $14.84 M(-17.5%) |
| Dec 2023 | $17.98 M(+70.8%) | $17.98 M(+29.3%) |
| Sep 2023 | - | $13.91 M(+36.1%) |
| Jun 2023 | - | $10.22 M(+43.6%) |
| Mar 2023 | - | $7.12 M(-32.4%) |
| Dec 2022 | $10.53 M | $10.53 M(+186.0%) |
| Sep 2022 | - | $3.68 M(-19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.58 M(+17.3%) |
| Mar 2022 | - | $3.91 M(+43.8%) |
| Dec 2021 | $2.72 M(-17.6%) | $2.72 M(+67.3%) |
| Sep 2021 | - | $1.62 M(-19.3%) |
| Jun 2021 | - | $2.01 M(-6.0%) |
| Mar 2021 | - | $2.14 M(-35.0%) |
| Dec 2020 | $3.30 M(-51.6%) | $3.30 M(-34.7%) |
| Nov 2020 | - | $5.05 M |
| Dec 2019 | $6.81 M | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual total liabilities?
- What is the all time high annual total liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual total liabilities year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly total liabilities year-on-year change?
What is Reviva Pharmaceuticals Holdings annual total liabilities?
The current annual total liabilities of RVPH is $17.98 M
What is the all time high annual total liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual total liabilities is $17.98 M
What is Reviva Pharmaceuticals Holdings annual total liabilities year-on-year change?
Over the past year, RVPH annual total liabilities has changed by +$7.45 M (+70.78%)
What is Reviva Pharmaceuticals Holdings quarterly total liabilities?
The current quarterly total liabilities of RVPH is $17.61 M
What is the all time high quarterly total liabilities for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly total liabilities is $17.98 M
What is Reviva Pharmaceuticals Holdings quarterly total liabilities year-on-year change?
Over the past year, RVPH quarterly total liabilities has changed by +$3.71 M (+26.64%)